rs879255081
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PS4_SupportingPP3PP4
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.1946C>T (p.Pro649Leu) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PP3, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 28 October 2024.The supporting evidence is as follows:PM2: PopMax MAF = 8.475e-7 (0.00008475%) in European (non-Finnish) (gnomAD v4.1.0).PP3: REVEL = 0.777.PS4_Supporting, PP4: Variant meets PM2 and is identified in at least 2 index cases who fulfill Simon Broome criteria for FH, after alternative causes of high cholesterol were excluded (1 case from Day et al 1997, PMID 9259195; 1 case from Tosi et al 2007, PMID 17094996). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10585689/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLR | NM_000527.5 | c.1946C>T | p.Pro649Leu | missense_variant | Exon 13 of 18 | ENST00000558518.6 | NP_000518.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461860Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727230
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Pathogenic:2Uncertain:4
This missense variant replaces proline with leucine at codon 649 of the LDLR protein. This variant is also known as p.Pro628Leu in the mature protein. This variant alters a conserved AA1 residue in the LDLR type B repeat 6 of the LDLR protein (a.a. 616-658), where pathogenic missense variants are found enriched (ClinVar-LDLR). Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in four individuals affected with familial hypercholesterolemia (PMID: 9259195, 17094996, 18325082, 35913489, 36325061; ClinVar SCV000503435.1). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
- -
The NM_000527.5(LDLR):c.1946C>T (p.Pro649Leu) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PP3, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 28 October 2024. The supporting evidence is as follows: PM2: PopMax MAF = 8.475e-7 (0.00008475%) in European (non-Finnish) (gnomAD v4.1.0). PP3: REVEL = 0.777. PS4_Supporting, PP4: Variant meets PM2 and is identified in at least 2 index cases who fulfill Simon Broome criteria for FH, after alternative causes of high cholesterol were excluded (1 case from Day et al 1997, PMID 9259195; 1 case from Tosi et al 2007, PMID 17094996). -
- -
- -
- -
Familial hypercholesterolemia Pathogenic:2
Variant summary: LDLR c.1946C>T (p.Pro649Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251472 control chromosomes. c.1946C>T has been reported in the literature in individuals affected with Familial Hypercholesterolemia (Day_1997, Tosi_2007, Du_2022, Sustar_2022, Schwaninger_2023). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 9259195, 36325061, 37417318, 35913489, 17094996). ClinVar contains an entry for this variant (Variation ID: 252122). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 649 of the LDLR protein (p.Pro649Leu). This missense change has been observed in individual(s) with familial hypercholesterolemia (PMID: 9259195). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Pro649 amino acid residue in LDLR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20809525; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LDLR protein function. ClinVar contains an entry for this variant (Variation ID: 252122). This variant is also known as P628L. -
not provided Pathogenic:1Uncertain:1
LDLR: PM1, PM2, PS4:Moderate, PP4 -
The LDLR c.1946C>T (p.Pro649Leu) variant has been reported in the published literature in individuals with Familial hypercholesterolemia (PMIDs: 9259195 (1997), 17094996 (2007), 18325082 (2008), 35913489 (2022), and 36325061 (2022)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
Cardiovascular phenotype Uncertain:1
The p.P649L variant (also known as c.1946C>T), located in coding exon 13 of the LDLR gene, results from a C to T substitution at nucleotide position 1946. The proline at codon 649 is replaced by leucine, an amino acid with similar properties. This alteration has been reported in familial hypercholesterolemia (FH) cohorts (Day IN et al. Hum Mutat, 1997;10:116-27; Tosi I et al. Atherosclerosis, 2007 Sep;194:102-11). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at